Skip to main content
Premium Trial:

Request an Annual Quote

OptraHealth, InformedDNA Partner for Remote Genetic Counseling

NEW YORK – OptraHealth said today that it is partnering with InformedDNA to make the latter's network of genetic counselors remotely available to users of the OptraHealth GeneFax system.

As a result of the telegenetics partnership consumers on the GeneFax Counselor Connect scheduling platform will be able to reach InformedDNA counselors online to ask questions about genetic and prenatal testing, enhancing the artificial intelligence-driven GeneFax chatbot model offered by San Jose, California-based OptraHealth.

Notably, the GeneFax system allows consumers and healthcare providers to query genetic data via a chatbot, mobile application, and voice assistants like Amazon's Alexa, Microsoft's Cortana, and Google Home. 

"I strongly believe that the combination of GeneFax's AI technology and expert genetic counseling services of InformedDNA will extend the reach of genetic testing and engage users meaningfully," OptraHealth Founder and CEO Gauri Naik said in a statement. "It will also empower users to get more out of genetic testing in order to take control of their health."

"Partnering with OptraHealth opens yet another avenue to help patients, providers, labs, and payors better understand the genetic landscape, including testing and treatment considerations," Amber Trived, chief innovation officer of St. Petersburg, Florida-based InformedDNA, said. "Now, these audiences will have even more resources at their fingertips to help navigate the complexities related to genetic testing."

InformedDNA already provides counseling and management services to the likes of Coriell Institute for Medical Research, WIRB-Copernicus Group, and AIM Specialty Health to support drug development for precision medicine and to help payors manage appropriate genetic testing utilization.

The Scan

For STEM Students to Stay

New policy changes will make it easier for international STEM students to stay in the US after graduation, the Wall Street Journal reports.

To Inform or Not, To Know or Not

The New York Times writes that some genetic biobanks may re-contact donors if they spot something troublesome, but it notes that not all donors want that information.

Rapid Test Studies

Researchers are examining why rapid tests may be less effective at detecting the Omicron variant and how to improve them, NPR says.

PLOS Papers on SARS-CoV-2 Diversity in Delaware, Metastatic Breast Cancer, Adiposity GWAS

In PLOS this week: genomic analysis of SARS-CoV-2 isolates from Delaware, gene expression and protein-protein interaction patterns in metastatic breast cancer, and more.